AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

August 4, 2021

Period of Report

August 3, 2021

Accession Number

0001096906-21-001784

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →